104 related articles for article (PubMed ID: 8095408)
1. Electrospray ionization mass spectrometry as a mechanistic tool: mass of human leucocyte elastase and a beta-lactam-derived E-I complex.
Knight WB; Swiderek KM; Sakuma T; Calaycay J; Shively JE; Lee TD; Covey TR; Shushan B; Green BG; Chabin R
Biochemistry; 1993 Mar; 32(8):2031-5. PubMed ID: 8095408
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of human serine proteases by substituted 2-azetidinones.
Knight WB; Chabin R; Green B
Arch Biochem Biophys; 1992 Aug; 296(2):704-8. PubMed ID: 1632655
[TBL] [Abstract][Full Text] [Related]
3. Mechanism of inhibition of human leucocyte elastase by beta-lactams. 3. Use of electrospray ionization mass spectrometry and two-dimensional NMR techniques to identify beta-lactam-derived E-I complexes.
Underwood DJ; Green BG; Chabin R; Mills S; Doherty JB; Finke PE; MacCoss M; Shah SK; Burgey CS; Dickinson TA
Biochemistry; 1995 Nov; 34(44):14344-55. PubMed ID: 7578038
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of elastase by N-sulfonylaryl beta-lactams: anatomy of a stable acyl-enzyme complex.
Wilmouth RC; Westwood NJ; Anderson K; Brownlee W; Claridge TD; Clifton IJ; Pritchard GJ; Aplin RT; Schofield CJ
Biochemistry; 1998 Dec; 37(50):17506-13. PubMed ID: 9860865
[TBL] [Abstract][Full Text] [Related]
5. Mechanism of inhibition of human leucocyte elastase by beta-lactams. 2. Stability, reactivation kinetics, and products of beta-lactam-derived E-I complexes.
Green BG; Chabin R; Mills S; Underwood DJ; Shah SK; Kuo D; Gale P; Maycock AL; Liesch J; Burgey CS
Biochemistry; 1995 Nov; 34(44):14331-43. PubMed ID: 7578037
[TBL] [Abstract][Full Text] [Related]
6. Mechanism of inhibition of human leucocyte elastase by monocyclic beta-lactams.
Chabin R; Green BG; Gale P; Maycock AL; Weston H; Dorn CP; Finke PE; Hagmann WK; Hale JJ; MacCoss M
Biochemistry; 1993 Aug; 32(34):8970-80. PubMed ID: 8364042
[TBL] [Abstract][Full Text] [Related]
7. Mechanistic insights into the inhibition of serine proteases by monocyclic lactams.
Wilmouth RC; Kassamally S; Westwood NJ; Sheppard RJ; Claridge TD; Aplin RT; Wright PA; Pritchard GJ; Schofield CJ
Biochemistry; 1999 Jun; 38(25):7989-98. PubMed ID: 10387042
[TBL] [Abstract][Full Text] [Related]
8. Specificity, stability, and potency of monocyclic beta-lactam inhibitors of human leucocyte elastase.
Knight WB; Green BG; Chabin RM; Gale P; Maycock AL; Weston H; Kuo DW; Westler WM; Dorn CP; Finke PE
Biochemistry; 1992 Sep; 31(35):8160-70. PubMed ID: 1525156
[TBL] [Abstract][Full Text] [Related]
9. Inhibition by recombinant SLPI and half-SLPI (Asn55-Ala107) of elastase and cathepsin G activities: consequence for neutrophil-platelet cooperation.
Renesto P; Balloy V; Kamimura T; Masuda K; Imaizumi A; Chignard M
Br J Pharmacol; 1993 Apr; 108(4):1100-6. PubMed ID: 8097952
[TBL] [Abstract][Full Text] [Related]
10. Orally active beta-lactam inhibitors of human leukocyte elastase-1. Activity of 3,3-diethyl-2-azetidinones.
Shah SK; Dorn CP; Finke PE; Hale JJ; Hagmann WK; Brause KA; Chandler GO; Kissinger AL; Ashe BM; Weston H
J Med Chem; 1992 Oct; 35(21):3745-54. PubMed ID: 1433189
[TBL] [Abstract][Full Text] [Related]
11. Clarification of mechanism of human sputum elastase inhibition by a new inhibitor, ONO-5046, using electrospray ionization mass spectrometry.
Nakayama Y; Odagaki Y; Fujita S; Matsuoka S; Hamanaka N; Nakai H; Toda M
Bioorg Med Chem Lett; 2002 Sep; 12(17):2349-53. PubMed ID: 12161131
[TBL] [Abstract][Full Text] [Related]
12. DNA from bronchial secretions modulates elastase inhibition by alpha(1)-proteinase inhibitor and oxidized secretory leukoprotease inhibitor.
Ying QL; Simon SR
Am J Respir Cell Mol Biol; 2000 Oct; 23(4):506-13. PubMed ID: 11017916
[TBL] [Abstract][Full Text] [Related]
13. Glycosaminoglycans regulate elastase inhibition by oxidized secretory leukoprotease inhibitor.
Ying QL; Kemme M; Saunders D; Simon SR
Am J Physiol; 1997 Mar; 272(3 Pt 1):L533-41. PubMed ID: 9124611
[TBL] [Abstract][Full Text] [Related]
14. Secretory leucocyte proteinase inhibitor: inhibition of fibronectin degradation by neutrophil elastase.
Gervaix A; Thompson R; Bieth JG; Nick HP; Suter S
Eur Respir J; 1992 May; 5(5):566-75. PubMed ID: 1351853
[TBL] [Abstract][Full Text] [Related]
15. Orally active beta-lactam inhibitors of human leukocyte elastase. 3. Stereospecific synthesis and structure-activity relationships for 3,3-dialkylazetidin-2-ones.
Finke PE; Shah SK; Fletcher DS; Ashe BM; Brause KA; Chandler GO; Dellea PS; Hand KM; Maycock AL; Osinga DG
J Med Chem; 1995 Jun; 38(13):2449-62. PubMed ID: 7608910
[TBL] [Abstract][Full Text] [Related]
16. Influence of plasma proteinase inhibitors and the secretory leucocyte proteinase inhibitor on pancreatic elastase-induced degradation of some plasma proteins.
Håkansson HO; Ohlsson K
Gastroenterol Jpn; 1992 Oct; 27(5):652-6. PubMed ID: 1358738
[TBL] [Abstract][Full Text] [Related]
17. Regulation of secretory leukocyte proteinase inhibitor (SLPI) and elastase-specific inhibitor (ESI/elafin) in human airway epithelial cells by cytokines and neutrophilic enzymes.
Sallenave JM; Shulmann J; Crossley J; Jordana M; Gauldie J
Am J Respir Cell Mol Biol; 1994 Dec; 11(6):733-41. PubMed ID: 7946401
[TBL] [Abstract][Full Text] [Related]
18. Secretory leukocyte proteinase inhibitor is a major leukocyte elastase inhibitor in human neutrophils.
Sallenave JM; Si Tahar M; Cox G; Chignard M; Gauldie J
J Leukoc Biol; 1997 Jun; 61(6):695-702. PubMed ID: 9201260
[TBL] [Abstract][Full Text] [Related]
19. Novel mechanism of inhibition of elastase by beta-lactams is defined by two inhibitor crystal complexes.
Taylor P; Anderson V; Dowden J; Flitsch SL; Turner NJ; Loughran K; Walkinshaw MD
J Biol Chem; 1999 Aug; 274(35):24901-5. PubMed ID: 10455164
[TBL] [Abstract][Full Text] [Related]
20. Potential role of recombinant secretory leucoprotease inhibitor in the prevention of neutrophil mediated matrix degradation.
Llewellyn-Jones CG; Lomas DA; Stockley RA
Thorax; 1994 Jun; 49(6):567-72. PubMed ID: 7912452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
